Ensign Peak Advisors
AMGN icon

Ensign Peak Advisors’s Amgen AMGN Stock Holding History

Ensign Peak Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.8M Buy
236,929
+22,550
+11% +$7.72M 0.14% 135
2026
Q1 		$75.4M Buy
214,379
+28,517
+15% +$10.2M 0.14% 145
2025
Q4 		$60.8M Sell
185,862
-40,492
-18% -$12.8M 0.11% 164
2025
Q3 		$63.9M Sell
226,354
-84,766
-27% -$24.6M 0.1% 166
2025
Q2 		$86.9M Sell
311,120
-106,567
-26% -$30.2M 0.15% 134
2025
Q1 		$130M Buy
417,687
+81,632
+24% +$24.1M 0.25% 83
2024
Q4 		$87.6M Buy
336,055
+68,990
+26% +$20.5M 0.16% 123
2024
Q3 		$86.1M Sell
267,065
-1,895
-0.7% -$620K 0.15% 120
2024
Q2 		$84M Sell
268,960
-4,002
-1% -$1.18M 0.15% 117
2024
Q1 		$77.6M Sell
272,962
-391,393
-59% -$115M 0.14% 145
2023
Q4 		$191M Sell
664,355
-96,069
-13% -$26.2M 0.38% 62
2023
Q3 		$204M Buy
760,424
+384,955
+103% +$96.1M 0.44% 53
2023
Q2 		$83.4M Sell
375,469
-19,028
-5% -$4.42M 0.17% 116
2023
Q1 		$95.4M Sell
394,497
-108,923
-22% -$26.7M 0.21% 98
2022
Q4 		$132M Sell
503,420
-4,134
-0.8% -$1.11M 0.3% 85
2022
Q3 		$114M Sell
507,554
-6,530
-1% -$1.58M 0.28% 87
2022
Q2 		$125M Buy
514,084
+277,374
+117% +$68M 0.3% 81
2022
Q1 		$57.2M Buy
236,710
+59,155
+33% +$13.6M 0.12% 162
2021
Q4 		$39.9M Buy
177,555
+98,853
+126% +$20.9M 0.08% 221
2021
Q3 		$16.7M Sell
78,702
-7,155
-8% -$1.65M 0.03% 339
2021
Q2 		$20.9M Sell
85,857
-905
-1% -$223K 0.04% 307
2021
Q1 		$21.6M Sell
86,762
-99,457
-53% -$23.7M 0.05% 301
2020
Q4 		$42.8M Sell
186,219
-96,353
-34% -$22.2M 0.1% 179
2020
Q3 		$71.8M Buy
282,572
+15,465
+6% +$3.83M 0.18% 107
2020
Q2 		$63M Sell
267,107
-69,417
-21% -$15.8M 0.17% 111
2020
Q1 		$68.2M Buy
336,524
+38,534
+13% +$8.42M 0.23% 88
2019
Q4 		$71.8M Buy
+297,990
New +$65.7M 0.19% 97

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ensign Peak Advisors's AMGN Position: Q2 2026 in Review

Ensign Peak Advisors increased its Amgen (AMGN) stake by 11% in Q2 2026, buying an estimated $7.72M and bringing the position to 236,929 shares worth $85.8M. The position accounts for 0.14% of the portfolio, ranked #135.

Ensign Peak Advisors first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $204M in Q3 2023. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ensign Peak Advisors held 236,929 shares of Amgen worth $85.8M as of Q2 2026.
  • Ensign Peak Advisors bought 22,550 Amgen shares in Q2 2026, an estimated $7.72M.
  • Amgen made up 0.14% of Ensign Peak Advisors's portfolio in Q2 2026, its #135 holding.
  • Ensign Peak Advisors first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Amgen position peaked at $204M in Q3 2023.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.